US 9701639
Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
granted A61KA61K31/225A61K31/47
Quick answer
US patent 9701639 (Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/225, A61K31/47, A61K45/06, A61P